Drug Profile
Cariel
Latest Information Update: 07 Nov 2000
Price :
$50
*
At a glance
- Originator SyntheMed
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Skin ulcer
Most Recent Events
- 07 Nov 2000 No-Development-Reported for Skin ulcer in Israel (Topical)
- 25 Jul 1997 Discontinued-III for Skin ulcer in European Union (Topical)
- 06 Nov 1996 Phase-III clinical trials for Skin ulcer in European Union (Topical)